Register for IPO Updates
US IPO Stats
IPO Industry Breakdown
Largest Global IPOs
Largest US IPOs
IPO News Archive
New Ways to Invest in IPOs - IPO ETFs
US IPO Weekly Recap: Volatility rules a week with no IPOs and 6 new filings
Analyst IPO Market Commentary
It's all quiet in the IPO market as hell breaks loose elsewhere.
The VIX volatility index spiked above 40 for the first time since August 2011, but ended the week at 26. With an especially-late Labor Day this year, that number has two weeks to slide below 20 before volatility threatens to derail the IPO market. IPO returns will also need to improve, as nearly half of 2015 IPOs trade below their offer price for the second week in a row. Assuming markets stabilize, this could translate into
greater buying power for IPO investors
, especially for cash-strapped biotechs and debt-burdened LBOs.
IPO pipeline update: Health care pulls through
Six IPOs filed in the past week, and five were health care. The sector currently represents 44% of IPOs year-to-date. 11 other companies updated registration documents, signaling plans to go public soon.
IPO filings included one regional bank, one medical systems LBO and four biotechs. More than other sectors, health care has greater immunity from turmoil in commodities and emerging markets. Out of IPOs in the past 90 days, seven of the eight that trade more than 50% above the IPO price are health care. Yet regardless of the sector, every IPO will be challenged if this level of volatility continues to rock the markets.
Three large biotech IPOs
Three biotech IPOs this week filed with a proposed deal size of more than $80 million. Larger biotech IPOs have historically outperformed, and each of the three boasts top-tier investors such as NEA, Third Rock, Fidelity and RA Capital or premium pharmaceutical partners like Pfizer, Baxalta and Roche.
Another highly-levered billion-dollar IPO
Acelity Holdings (
), an LBO'd medical systems maker, filed this week for an IPO that we estimate could raise $1 billion. With $4.8 billion in debt (6.6x LTM EBITDA), Acelity joins a growing list of large and highly-levered LBO'd IPOs, as PE firms seek to exit their investments and pay down debt ahead of a potential rate hike in September. Recent filers include Neiman Marcus (
; debt of 6.6x LTM EBITDA), First Data (
; 8.1x), Albertsons (
; 5.4x), Surgery Partners (
; 8.9x), Mauser Group (
; 6.5x) and ADS Waste (
6 IPOs Filed during the week of August 24
San Antonio, TX
LBO'd provider of advanced wound care systems and tissue implants.
South San Francisco, CA
Third Rock, Pfizer
Cowen & Co.
Developing cancer immunotherapies that do not target healthy cells.
RA Capital, NEA
Developing therapies for Cushing's syndrome and acromegaly.
Developing microRNA replacement therapies for cancer.
Commercial bank with 16 locations in Houston and $2 billion in assets.
Advanced Inhalation Therapies
Inhaled nitric oxide drug-device therapies for respiratory infections.
Source: IPO ETF manager Renaissance Capital
Find out why institutional investors rely on Renaissance Capital's
for these IPOs.
Follow us on Twitter (
) for IPO news as it happens and
register for our updates
on the IPO market.
IPO Market Snapshot
The Renaissance IPO Indices are market cap weighted baskets of newly public companies. The Renaissance IPO Index has traded down 3.9% year-to-date, below the S&P 500's 3.4% loss due to the decline of Alibaba and Twitter. Renaissance Capital's
(NYSE: IPO) tracks the index, and
top ETF holdings
include Alibaba (
), Hilton Worldwide (
) and Twitter (
). The Renaissance International IPO Index has traded down 1.0% year-to-date, compared to -4.6% for the ACWX. Renaissance Capital’s International
(NYSE: IPOS) tracks the index, and
top ETF Holdings
include Recruit Holdings and Cheil Industries.
To find out if this is the best ETF for you, visit our
IPO Investing page
Keywords / Tickers:
ETF Express Award:
ETFExpress awards are based on a 'peer review system' whereby readers - including institutional and high net worth investors as well as managers and other industry professionals at fund administrators, brokers, custodians and advisers - are invited to elect a 'best in class' in a series of categories via an online survey. In each category, the firms with the most votes at the end of the voting period are subject to a final review by ETFExpress's Senior Editorial team.
Past performance does not guarantee future results. The performance data quoted represents past performance and current returns may be lower or higher. The investment return and principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than the original cost. Investors should consider the investment objectives, risks, charges and expenses carefully before investing.
As stated in the Prospectus, the total annual operating expenses for the Fund was 3.48%. The Adviser has contractually agreed to keep net expenses from exceeding 2.50% of the Fund's average daily net assets for at least a year from the date of the Prospectus and for an indefinite period thereafter subject to annual re-approval of the agreement by the Board of Trustees.
An investor cannot invest directly in an index. Index returns do not represent Fund returns. The Index does not charge management fees or brokerage expenses, nor does the Index lend securities, and no revenues from securities lending were added to the performance shown.
Definitions: Net Asset Value (NAV) of the fund is calculated by dividing the total value of all the securities in its portfolio, less any liabilities, by the number of fund shares outstanding. Market Price is current value at which an asset or service can be bought or sold. Premium/Discount is provided to show the comparison of the daily net asset value (NAV) and the midpoint of the closing bid/ask for each of the funds.
Renaissance IPO Index® (IPOUSA)
is a stock market index based upon a portfolio of U.S.-listed newly public companies that includes securities prior to their inclusion in core U.S. equity portfolios.
Renaissance International IPO Index® (IPOXUS)
is a stock market index based upon a portfolio of newly public companies listed on non-U.S. exchanges.
The S&P 500® Index (SPX) is a stock market index which includes 500 U.S. listed companies and seeks to capture approximately 80% coverage of available U.S. market capitalization.
Risk Disclosure: Investments in the
Renaissance IPO ETF, symbol "IPO"
Renaissance International IPO ETF, symbol "IPOS"
(the "ETFs"), and the
Global IPO Fund, symbol "IPOSX"
(the "Mutual Fund") are subject to investment risk, including possible loss of the principal amounts invested. The ETFs and the Mutual Fund (the "Funds") invest in companies that have recently completed initial public offerings. These stocks are unseasoned equities lacking trading history, a track record of reporting to investors and widely available research coverage which many result in extreme price volatility. Due to a greater number of IPOs in certain segments, the Funds may also be subject to information technology and financial sector risk, small and mid-capitalization company risk, and, for the Renaissance International IPO ETF, emerging markets risk. The Funds may hold securities in the form of Depository Receipts, REITs, and Partnership Units which have greater risks than common shares. The strategies have high portfolio turnover and securities lending risks. The returns of the ETFs may not match the return of the respective indices. The ETFs are classified as non-diversified investment companies subject to concentration risk.
Prospectus: Investors should consider the investment objectives, risks, charges and expenses carefully before investing. For a prospectus and/or summary prospectus with this and other information, please visit
. Read the prospectus carefully before investing. Renaissance Capital Investments, Inc., distributor for the Mutual Fund. Foreside Fund Services, LLC, distributor for the ETFs, 1-866-486-6645.
Definitions: The Renaissance IPO Index® is a stock market index based upon a portfolio of U.S.-listed newly public companies that includes securities prior to their inclusion in core U.S. equity portfolios. The S&P 500® Index is a stock market index based on the market capitalizations of 500 large companies whose common stock is publicly traded on the NYSE or Nasdaq.
The information contained herein is proprietary and copyrighted. The media is welcome to use our information and ideas, provided that the following sourcing is included: Renaissance Capital - manager of IPO-focused ETFs.
The information and opinions expressed herein were prepared by Renaissance Capital's research analysts and do not constitute an offer to buy or sell any security. Renaissance Capital, the Renaissance IPO ETF (symbol: IPO), the Renaissance International IPO ETF (symbol: IPOS), or the Global IPO Fund (symbol: IPOSX), may have investments in securities of companies mentioned.
Register for Updates
Renaissance Capital LLC is an SEC-registered investment adviser.
Renaissance Capital Investments, Inc. is a
-registered broker-dealer, and member of
© 2016 Renaissance Capital LLC. All rights reserved.